- Home
- IPHA vs NNY Comparison
IPHA vs NNY Comparison
Compare IPHA & NNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- NNY
- Stock Information
- Founded
- IPHA 1999
- NNY 1987
- Country
- IPHA France
- NNY United States
- Employees
- IPHA N/A
- NNY N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- NNY Investment Managers
- Sector
- IPHA Health Care
- NNY Finance
- Exchange
- IPHA Nasdaq
- NNY Nasdaq
- Market Cap
- IPHA 160.1M
- NNY 153.2M
- IPO Year
- IPHA 2019
- NNY N/A
- Fundamental
- Price
- IPHA $1.74
- NNY $8.07
- Analyst Decision
- IPHA Strong Buy
- NNY
- Analyst Count
- IPHA 1
- NNY 0
- Target Price
- IPHA $11.00
- NNY N/A
- AVG Volume (30 Days)
- IPHA 11.2K
- NNY 50.9K
- Earning Date
- IPHA 09-11-2025
- NNY 01-01-0001
- Dividend Yield
- IPHA N/A
- NNY 4.04%
- EPS Growth
- IPHA N/A
- NNY N/A
- EPS
- IPHA N/A
- NNY N/A
- Revenue
- IPHA $20,831,349.00
- NNY N/A
- Revenue This Year
- IPHA $209.83
- NNY N/A
- Revenue Next Year
- IPHA $83.15
- NNY N/A
- P/E Ratio
- IPHA N/A
- NNY N/A
- Revenue Growth
- IPHA N/A
- NNY N/A
- 52 Week Low
- IPHA $1.29
- NNY $7.58
- 52 Week High
- IPHA $3.51
- NNY $8.87
- Technical
- Relative Strength Index (RSI)
- IPHA 42.70
- NNY 41.43
- Support Level
- IPHA $1.71
- NNY $8.05
- Resistance Level
- IPHA $1.90
- NNY $8.13
- Average True Range (ATR)
- IPHA 0.08
- NNY 0.06
- MACD
- IPHA 0.00
- NNY 0.00
- Stochastic Oscillator
- IPHA 47.62
- NNY 53.00
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About NNY Nuveen New York Municipal Value Fund
Nuveen New York Municipal Value Fund Inc is a diversified closed-end management investment company. Its investment objective is to provide current income exempt from both regular federal and New York state income taxes, by investing in a portfolio of municipal obligations issued by state and local government authorities within the state of New York or certain U.S. territories.